459 related articles for article (PubMed ID: 29675551)
1. Magnetic nanoparticles based cancer therapy: current status and applications.
Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
[TBL] [Abstract][Full Text] [Related]
2. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
5. Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich's "magic (nano)bullet" for cancer theranostics?
Datta NR; Krishnan S; Speiser DE; Neufeld E; Kuster N; Bodis S; Hofmann H
Cancer Treat Rev; 2016 Nov; 50():217-227. PubMed ID: 27756009
[TBL] [Abstract][Full Text] [Related]
6. Fe
Li Y; Zhang H
Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
Amiri M; Salavati-Niasari M; Akbari A
Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
[TBL] [Abstract][Full Text] [Related]
8. Functionalized magnetic nanoparticles for biomedical applications.
Gudovan D; Balaure PC; Mihăiescu DE; Fudulu A; Purcăreanu B; Radu M
Curr Pharm Des; 2015; 21(42):6038-54. PubMed ID: 26503153
[TBL] [Abstract][Full Text] [Related]
9. Cancer theranostics: the rise of targeted magnetic nanoparticles.
Cole AJ; Yang VC; David AE
Trends Biotechnol; 2011 Jul; 29(7):323-32. PubMed ID: 21489647
[TBL] [Abstract][Full Text] [Related]
10. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
11. The use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices.
Hajba L; Guttman A
Biotechnol Adv; 2016; 34(4):354-361. PubMed ID: 26853617
[TBL] [Abstract][Full Text] [Related]
12. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
13. Combining unique properties of dendrimers and magnetic nanoparticles towards cancer theranostics.
Chandra S; Nigam S; Bahadur D
J Biomed Nanotechnol; 2014 Jan; 10(1):32-49. PubMed ID: 24724497
[TBL] [Abstract][Full Text] [Related]
14. Iron oxide magnetic nanoparticles as antimicrobials for therapeutics.
de Toledo LAS; Rosseto HC; Bruschi ML
Pharm Dev Technol; 2018 Apr; 23(4):316-323. PubMed ID: 28565928
[TBL] [Abstract][Full Text] [Related]
15. Theranostic magnetic nanoparticles.
Yoo D; Lee JH; Shin TH; Cheon J
Acc Chem Res; 2011 Oct; 44(10):863-74. PubMed ID: 21823593
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
17. Mean-field and linear regime approach to magnetic hyperthermia of core-shell nanoparticles: can tiny nanostructures fight cancer?
Carrião MS; Bakuzis AF
Nanoscale; 2016 Apr; 8(15):8363-77. PubMed ID: 27046437
[TBL] [Abstract][Full Text] [Related]
18. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Polymeric-Magnetic Nanoparticles in Cancer Treatments.
Bonilla AM; Gonzalez PH
Curr Pharm Des; 2017; 23(35):5392-5402. PubMed ID: 28741458
[TBL] [Abstract][Full Text] [Related]
20. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
